| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.17 | 0.0007 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.17 | 0.005 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.01 |